Autologous Graft-Versus-Host Disease in a Child with Stage IV Neuroblastoma

2014 ◽  
Vol 32 (2) ◽  
pp. 276-279 ◽  
Author(s):  
Jessica Kaffenberger ◽  
Sarah A. Basak ◽  
Michael Ioffreda
Keyword(s):  
Graft Versus Host Disease ◽  
Stage Iv ◽  
Host Disease ◽  
Graft Versus Host ◽  
Autologous Graft ◽  
Stage Iv Neuroblastoma

Eruption of lymphocyte recovery or autologous graft-versus-host disease?

2008 ◽  
Vol 47 ◽  
pp. 32-34 ◽  
Author(s):  
Ruud G. L. Nellen ◽  
Arienne M. W. van Marion ◽  
Jorge Frank ◽  
Pamela Poblete-Gutiérrez ◽  
Peter M. Steijlen
Keyword(s):  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host ◽  
Autologous Graft

scholarly journals Autologous Graft Versus Host Disease: An Emerging Complication in Patients with Multiple Myeloma

2014 ◽  
Vol 20 (2) ◽  
pp. S261-S262
Author(s):  
Anu Batra ◽  
Michele Cottler-Fox ◽  
Terry Harville ◽  
Bobbie Shirlonda Rhodes-Clark ◽  
Issam Makhoul ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host ◽  
Autologous Graft

scholarly journals CD4+ T Cells Prevent Skin Autoimmunity During Chronic Autologous Graft-Versus-Host-Disease

2004 ◽  
Vol 4 (6) ◽  
pp. 872-878 ◽  
Author(s):  
Olivier Hequet ◽  
Marc Vocanson ◽  
Pierre Saint-Mezard ◽  
Dominique Kaiserlian ◽  
Jean Francois Nicolas ◽  
...  
Keyword(s):  
T Cells ◽  
Graft Versus Host Disease ◽  
Cd4 T Cells ◽  
Host Disease ◽  
Graft Versus Host ◽  
Autologous Graft

scholarly journals Lyell-Like Acute Graft-Versus-Host-Disease

2021 ◽  
pp. 1-2
Author(s):  
Caroline de Lorenzi ◽  
◽  
Yassaman Alipour Tehrany ◽  
Sébastien Menzinger ◽  
◽  
...  
Keyword(s):  
Graft Versus Host Disease ◽  
Acute Gvhd ◽  
Stage Iv ◽  
Disease Stage ◽  
First Line ◽  
Literature Report ◽  
Host Disease ◽  
Graft Versus Host ◽  
Systemic Corticosteroids ◽  
Grade Ii

Stage IV acute cutaneous graft-versus-host-disease (GVHD) is nowadays rarely seen due to tissue typing done before transplant. The first line treatment for acute GVHD grade II-IV is systemic corticosteroids. However, although there is no consensus for refractory cases, literature report diverse therapies to be effective. We report the case of a 34 year-old patient with refractory acute cutaneous graft-versus-host-disease stage IV successfully treated with etanercept

Sign in / Sign up

Export Citation Format

Share Document